GLC determination of nanogram quantities of a new analgesic, nefopam, in human plasma

A sensitive and specific method was developed for the quantitative GLC determination of plasma nefopam levels. The method includes a multiple-step solvent extraction of the analgesic drug and the internal mass standard, orphenadrine. The accuracy, expressed as the relative error, was--4,6,6, and 4%...

Full description

Saved in:
Bibliographic Details
Published inJournal of pharmaceutical sciences Vol. 67; no. 12; p. 1720
Main Authors Schuppan, D, Hansen, C S, Ober, R E
Format Journal Article
LanguageEnglish
Published United States 01.12.1978
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:A sensitive and specific method was developed for the quantitative GLC determination of plasma nefopam levels. The method includes a multiple-step solvent extraction of the analgesic drug and the internal mass standard, orphenadrine. The accuracy, expressed as the relative error, was--4,6,6, and 4% at 20, 40, 70, and 130 ng/ml, respectively. The precision, expressed as relative standard deviation, was 17, 7, 3, and 5% at these same concentrations, respectively. Quantitation of nefopam in human plasma is possible down to 20 ng/ml with a 2-ml plasma sample; the sensitivity can be increased by using larger plasma samples. The methods was applied successfully to the determination of plasma nefopam levels in humans in pharmacokinetic studies at therapeutic doses.
ISSN:0022-3549
DOI:10.1002/jps.2600671223